BRCA1 and BRCA2 germline mutations contribute to a significant number (10-15%) of familial and hereditary breast and/or ovarian cancers. The proportion of high-risk families with breast and/or ovarian cancer cases due to mutations in these tumor suppressor genes varies widely among populations.